Tetracycline HCL Capsules — Class I drug recall D-1254-2020
Terminated recall by Avet Pharmaceuticals, Inc., reported 2020-04-15, distributed nationwide. Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl ca
| Recall number | D-1254-2020 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Avet Pharmaceuticals, Inc., East Brunswick, NJ, United States |
| Recall initiated | 2020-03-23 |
| Classified | 2020-04-27 |
| Reported by FDA | 2020-04-15 |
| Terminated | 2022-08-23 |
| Distributed | Nationwide (US) |
| Quantity | 17,524 bottles |
| Reason classes | specification failure |
| NDC | 23155-0017, 23155-0017-01, 23155-0018, 23155-0018-01 |
| Lot numbers | G190609, G190610, G190611, K190952, K190953, L191027, L191028 |
| Expiration dates | 2022-06-20, 2022-10-20, 2022-11-20 |
Product
Tetracycline HCL Capsules, USP, 500 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-018-01
Reason for recall
Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1254-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.